A Comprehensive Review of Leflunomide Analytical Analysis: Spectroscopic Technique, Chromatographic Condition, Detection Limits and Validation Parameters.
DOI:
https://doi.org/10.53555/AJBR.v28i2S.7544Keywords:
Leflunomide, RP HPLC-UV, LC-MS/MS, UV-Visible Spectroscopy, UPLCAbstract
Leflunomide is a medication that is used to treat the symptoms of rheumatoid arthritis. It is classified as a pyrimidine synthesis inhibitor (DMARD) type of therapy. Additionally, it improves physical functioning, lessen
joint damage, and slows the advancement of disease-related structural damage. The material published in different pharmaceutical publications has been thoroughly studied, and the instrumental analytical techniques created and employed for Leflunomide determination have also been examined. UV-Visible Spectroscopy, RP-HPLC-UV, LC-MS/MS, and UPLC are all included in this review. This article has also covered the use of these techniques for determining the amount of leflunomide in biological samples and pharmaceutical formulations.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sanket Gothi, Dr. Pragnesh Patani, Mr. Vijendra Rajan, Dr. Neha Tiwari (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.



